AQST Aquestive Therapeutics, Inc.
Nasdaq · SEC CIK 1398733 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $3.59M 19 sales by 9 insiders
- Filings on record
- 160 since 2021-08-27, latest 2026-09-16 14:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| Jung Cassie | COO | — | $664.6K |
| Boyd Peter E. | See Remarks | — | $257.3K |
| TOTH A ERNEST JR | CFO | — | $242.9K |
| BRAENDER LORI J | Corp. Sec | — | $167.2K |
| Kraus Carl N | Chief Medical Off | — | $141.9K |
| Krop Julie | Dir | — | $125.4K |
| Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| Zalewski Thomas A. | CLO | — | — |
Transactions 115
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 14:00 | 2026-09-15 | AQST | Barber Daniel | Pres, CEO, Dir | S - Sale | $4.82 | -25.0K | 652.3K | -4% | -$120.5K |
| DT | 2026-09-11 11:07 | 2026-09-09 | AQST | Korczynski Sherry | Chief Commercial Off | M - OptEx | $2.65 | +8,750 | 244.4K | +4% | +$23.2K |
| DT | 2026-09-11 11:07 | 2026-09-09 | AQST | Korczynski Sherry | Chief Commercial Off | S - Sale+OE | $5.22 | -8,750 | 235.7K | -4% | -$45.7K |
| D | 2026-09-10 09:21 | 2026-09-09 | AQST | Boyd Peter E. | CHRO | X - OptEx | $0.96 | +2,293 | 284.0K | +0.8% | +$2,201 |
| D | 2026-09-09 17:10 | 2026-09-08 | AQST | Barber Daniel | Pres, CEO, Dir | X - OptEx | $0.96 | +91.7K | 677.3K | +16% | +$88.1K |
| D | 2026-09-08 16:06 | 2026-09-03 | AQST | Jung Cassie | COO | X - OptEx | $0.96 | +4,587 | 206.8K | +2% | +$4,404 |
| T | 2026-08-18 16:13 | 2026-08-17 | AQST | Barber Daniel | Pres, CEO, Dir | S - Sale | $4.29 | -25.0K | 585.6K | -4% | -$107.2K |
| 2026-08-17 17:33 | 2026-08-14 | AQST | Korczynski Sherry | Chief Commercial Off | F - Tax | $4.25 | -2,714 | 235.7K | -1% | -$11.5K | |
| MT | 2026-07-17 13:15 | 2026-07-15+ | AQST | Barber Daniel | Pres, CEO | S - Sale | $4.01 | -25.0K | 610.6K | -4% | -$100.2K |
| DT | 2026-06-24 11:11 | 2026-06-23 | AQST | Krop Julie | Dir | M - OptEx | $0.7132 | +25.0K | 25.0K | New | +$17.8K |
| DT | 2026-06-24 11:11 | 2026-06-23 | AQST | Krop Julie | Dir | S - Sale+OE | $5.02 | -25.0K | 0 | -100% | -$125.4K |
| T | 2026-06-16 16:09 | 2026-06-15 | AQST | Barber Daniel | Pres, CEO | S - Sale | $4.16 | -25.0K | 635.6K | -4% | -$104.0K |
| 2026-06-09 14:48 | 2026-06-08 | AQST | Korczynski Sherry | Chief Commercial Off | F - Tax | $0.00 | -2,714 | 238.4K | -1% | $0 | |
| D | 2026-05-19 12:02 | 2026-05-18 | AQST | Zalewski Thomas A. | CLO | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| T | 2026-05-18 14:03 | 2026-05-15 | AQST | Barber Daniel | Pres, CEO | S - Sale | $4.29 | -8,257 | 660.6K | -1% | -$35.4K |
| 2026-05-18 12:36 | 2026-05-15 | AQST | Cioffi Melina | SVP, Regulatory Affairs | F - Tax | $4.17 | -1,667 | 273.2K | -0.6% | -$6,951 | |
| 2026-05-11 16:35 | 2026-05-07 | AQST | BRAENDER LORI J | Corp. Sec | F - Tax | $4.23 | -135.7K | 231.0K | -37% | -$574.0K | |
| 2026-05-07 17:34 | 2026-05-05 | AQST | Boyd Peter E. | CHRO | F - Tax | $4.18 | -56.8K | 281.7K | -17% | -$237.3K | |
| 2026-05-07 17:33 | 2026-05-05 | AQST | Barber Daniel | Pres, CEO | F - Tax | $4.18 | -335.9K | 668.8K | -33% | -$1.40M | |
| 2026-05-07 17:33 | 2026-05-05 | AQST | TOTH A ERNEST JR | CFO | F - Tax | $4.18 | -92.7K | 283.5K | -25% | -$387.3K | |
| 2026-05-07 17:32 | 2026-05-05 | AQST | Jung Cassie | COO | F - Tax | $4.18 | -72.7K | 202.2K | -26% | -$304.0K | |
| 2026-05-07 17:31 | 2026-05-05 | AQST | BRAENDER LORI J | Corp. Sec | F - Tax | $4.18 | -76.1K | 366.7K | -17% | -$318.3K | |
| D | 2026-03-11 | 2026-03-09 | AQST | Greenhawt Matthew J. | Chief Medical Off | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| D | 2026-03-11 | 2026-03-10 | AQST | Cioffi Melina | SVP, Regulatory Affairs | S - Sale | $4.17 | -25.3K | 274.9K | -8% | -$105.5K |
| D | 2026-03-11 | 2026-03-09 | AQST | Cioffi Melina | SVP, Regulatory Affairs | A - Grant | $0.00 | +100.0K | 300.2K | +50% | $0 |
| D | 2026-03-11 | 2026-03-10 | AQST | Korczynski Sherry | Chief Commercial Off | S - Sale | $4.17 | -15.7K | 241.1K | -6% | -$65.6K |
| D | 2026-03-11 | 2026-03-09 | AQST | Korczynski Sherry | Chief Commercial Off | A - Grant | $0.00 | +75.0K | 256.9K | +41% | $0 |
| D | 2026-03-11 | 2026-03-09 | AQST | Davis Matthew W. | Chief Development Off | A - Grant | $0.00 | +50.0K | 100.0K | +100% | $0 |
| D | 2026-03-11 | 2026-03-09 | AQST | Boyd Peter E. | CHRO | A - Grant | $0.00 | +80.0K | 368.3K | +28% | $0 |
| D | 2026-03-11 | 2026-03-10 | AQST | Boyd Peter E. | CHRO | S - Sale | $4.17 | -29.8K | 338.5K | -8% | -$124.3K |
| D | 2026-03-11 | 2026-03-10 | AQST | TOTH A ERNEST JR | CFO | S - Sale | $4.17 | -58.3K | 376.1K | -13% | -$242.9K |
| D | 2026-03-11 | 2026-03-09 | AQST | TOTH A ERNEST JR | CFO | A - Grant | $0.00 | +95.0K | 434.4K | +28% | $0 |
| D | 2026-03-11 | 2026-03-10 | AQST | BRAENDER LORI J | CLO | S - Sale | $4.17 | -40.1K | 442.9K | -8% | -$167.2K |
| D | 2026-03-11 | 2026-03-09 | AQST | BRAENDER LORI J | CLO | A - Grant | $0.00 | +80.0K | 483.0K | +20% | $0 |
| D | 2026-03-11 | 2026-03-09 | AQST | Jung Cassie | COO | A - Grant | $0.00 | +80.0K | 320.8K | +33% | $0 |
| D | 2026-03-11 | 2026-03-10 | AQST | Jung Cassie | COO | S - Sale | $4.17 | -45.8K | 275.0K | -14% | -$190.9K |
| D | 2026-03-11 | 2026-03-09 | AQST | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +262.0K | 1.19M | +28% | $0 |
| D | 2026-03-11 | 2026-03-10 | AQST | Barber Daniel | Pres, CEO | S - Sale | $4.17 | -180.7K | 1.00M | -15% | -$753.4K |
| 2025-12-05 | 2025-12-04 | AQST | Boyd Peter E. | CHRO | A - Grant | $0.00 | +20.0K | 288.3K | +7% | $0 | |
| 2025-12-04 | 2025-12-02 | AQST | Cioffi Melina | SVP, Regulatory Affairs | F - Tax | $5.93 | -2,083 | 200.2K | -1% | -$12.4K | |
| D | 2025-11-12 | 2025-11-10 | AQST | Davis Matthew W. | Chief Development Off | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| 2025-10-17 | 2025-10-15 | AQST | Kraus Carl N | Chief Medical Off | S - Sale | $7.00 | -20.3K | 282.5K | -7% | -$141.9K | |
| 2025-10-17 | 2025-10-15 | AQST | Boyd Peter E. | See Remarks | S - Sale | $7.00 | -10.0K | 268.3K | -4% | -$70.0K | |
| D | 2025-10-17 | 2025-10-15 | AQST | Jung Cassie | COO | S - Sale+OE | $7.01 | -67.6K | 240.8K | -22% | -$473.7K |
| D | 2025-10-17 | 2025-10-15 | AQST | Jung Cassie | COO | M - OptEx | $3.10 | +25.0K | 308.3K | +9% | +$77.5K |
| 2025-09-29 | 2025-09-26 | AQST | Boyd Peter E. | See Remarks | S - Sale | $6.30 | -10.0K | 278.3K | -3% | -$63.0K | |
| 2025-09-29 | 2025-09-26 | AQST | Barber Daniel | Pres, CEO, Dir | S - Sale | $6.03 | -91.3K | 923.4K | -9% | -$550.8K | |
| 2025-09-22 | 2025-09-19 | AQST | Barber Daniel | Pres, CEO, Dir | S - Sale | $6.00 | -400 | 1.01M | -0.0% | -$2,400 | |
| 2025-09-08 | 2025-09-05 | AQST | Boyd Peter E. | See Remarks | S - Sale | $5.30 | -15.0K | 288.3K | -5% | -$79.5K | |
| DM | 2025-09-08 | 2025-09-04 | AQST | Jung Cassie | COO | M - OptEx | $1.93 | +50.0K | 345.5K | +17% | +$96.5K |
| D | 2025-09-08 | 2025-09-04 | AQST | Jung Cassie | COO | S - Sale+OE | $5.00 | -62.2K | 283.3K | -18% | -$310.9K |
| 2025-08-15 | 2025-08-14 | AQST | Korczynski Sherry | Chief Commercial Off | A - Grant | $0.00 | +25.0K | 181.9K | +16% | $0 | |
| 2025-08-12 | 2025-08-09 | AQST | Kraus Carl N | Chief Medical Off | F - Tax | $3.90 | -10.8K | 302.7K | -3% | -$42.2K | |
| 2025-06-10 | 2025-06-09 | AQST | Korczynski Sherry | SVP Sales, Marketing | F - Tax | $3.54 | -2,714 | 156.9K | -2% | -$9,608 | |
| 2025-05-15 | 2025-05-15 | AQST | Cioffi Melina | SVP, Regulatory Affairs | A - Grant | $0.00 | +20.0K | 202.3K | +11% | $0 | |
| D | 2025-03-11 | 2025-03-07 | AQST | Korczynski Sherry | SVP Sales, Marketing | A - Grant | $0.00 | +90.0K | 165.0K | +120% | $0 |
| D | 2025-03-11 | 2025-03-07 | AQST | Korczynski Sherry | SVP Sales, Marketing | F - Tax | $2.65 | -5,428 | 159.6K | -3% | -$14.4K |
| D | 2025-03-11 | 2025-03-07 | AQST | Jung Cassie | COO | A - Grant | $0.00 | +80.0K | 313.1K | +34% | $0 |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Jung Cassie | COO | F - Tax | $2.64 | -17.5K | 295.5K | -6% | -$46.2K |
| D | 2025-03-11 | 2025-03-07 | AQST | TOTH A ERNEST JR | CFO | A - Grant | $0.00 | +110.0K | 358.3K | +44% | $0 |
| DM | 2025-03-11 | 2025-03-07+ | AQST | TOTH A ERNEST JR | CFO | F - Tax | $2.65 | -18.9K | 348.1K | -5% | -$50.2K |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Boyd Peter E. | See Remark | F - Tax | $2.65 | -14.3K | 303.3K | -5% | -$37.9K |
| D | 2025-03-11 | 2025-03-07 | AQST | Boyd Peter E. | See Remark | A - Grant | $0.00 | +80.0K | 317.6K | +34% | $0 |
| D | 2025-03-11 | 2025-03-07 | AQST | Wargacki Stephen | CSO | A - Grant | $0.00 | +115.0K | 376.4K | +44% | $0 |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Wargacki Stephen | CSO | F - Tax | $2.63 | -32.9K | 363.6K | -8% | -$86.6K |
| D | 2025-03-11 | 2025-03-07 | AQST | BRAENDER LORI J | CLO | A - Grant | $0.00 | +110.0K | 423.2K | +35% | $0 |
| DM | 2025-03-11 | 2025-03-07+ | AQST | BRAENDER LORI J | CLO | F - Tax | $2.65 | -20.2K | 413.6K | -5% | -$53.7K |
| DM | 2025-03-11 | 2025-03-07+ | AQST | Barber Daniel | Pres, CEO | F - Tax | $2.65 | -83.3K | 1.02M | -8% | -$220.8K |
| D | 2025-03-11 | 2025-03-07 | AQST | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +272.0K | 1.10M | +33% | $0 |
| D | 2025-03-11 | 2025-03-07 | AQST | Kraus Carl N | Chief Medical Off | F - Tax | $2.65 | -8,115 | 313.6K | -3% | -$21.5K |
| D | 2025-03-11 | 2025-03-07 | AQST | Kraus Carl N | Chief Medical Off | A - Grant | $0.00 | +70.0K | 321.7K | +28% | $0 |
| I | 2024-12-04 | 2024-12-02 | AQST | BRATTON DOUGLAS K | 10% | G - Gift | $0.00 | -40.0K | 199.8K | -17% | $0 |
| I | 2024-11-27 | 2024-11-26 | AQST | Jung Cassie | COO | S - Sale | $4.87 | -44 | 0 | -100% | -$214.28 |
| A | 2024-10-02 | 2024-03-09 | AQST | Barber Daniel | Pres, CEO | F - Tax | $4.88 | -56.8K | 826.5K | -6% | -$277.3K |
| A | 2024-10-02 | 2024-03-09 | AQST | Jung Cassie | SVP, Ops | F - Tax | $4.88 | -14.1K | 233.1K | -6% | -$68.9K |
| A | 2024-10-02 | 2024-03-09 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | F - Tax | $4.88 | -9,645 | 980.7K | -1.0% | -$47.1K |
| A | 2024-10-02 | 2024-03-09 | AQST | Wargacki Stephen | CSO | F - Tax | $4.88 | -19.5K | 261.4K | -7% | -$95.2K |
| 2024-08-12 | 2024-08-09 | AQST | Kraus Carl N | Chief Medical Off | F - Tax | $3.43 | -10.8K | 251.7K | -4% | -$37.1K | |
| 2024-06-11 | 2024-06-07 | AQST | Korczynski Sherry | SVP Sales, Marketing | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 | |
| 2024-05-13 | 2024-05-10 | AQST | Wargacki Stephen | CSO | A - Grant | $0.00 | +10.0K | 268.0K | +4% | $0 | |
| 2024-03-19 | 2024-03-15 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | S - Sale | $6.00 | -50.0K | 984.5K | -5% | -$300.0K | |
| 2024-03-12 | 2024-03-08 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | S - Sale | $5.19 | -25.0K | 1.04M | -2% | -$129.8K | |
| 2024-03-12 | 2024-03-09 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | F - Tax | $4.88 | -5,895 | 1.03M | -0.6% | -$28.8K | |
| 2024-03-12 | 2024-03-09 | AQST | Boyd Peter E. | See Remark | F - Tax | $4.88 | -8,370 | 237.6K | -3% | -$40.8K | |
| 2024-03-12 | 2024-03-09 | AQST | TOTH A ERNEST JR | SVP, CFO | F - Tax | $4.88 | -11.7K | 248.3K | -5% | -$57.1K | |
| M | 2024-03-12 | 2024-03-09+ | AQST | Wargacki Stephen | SVP, Research, Development | F - Tax | $4.88 | -13.0K | 258.0K | -5% | -$63.2K |
| M | 2024-03-12 | 2024-03-09+ | AQST | Jung Cassie | SVP, Ops | F - Tax | $4.88 | -9,432 | 238.9K | -4% | -$46.0K |
| 2024-03-12 | 2024-03-09 | AQST | BRAENDER LORI J | SVP, GC | F - Tax | $4.88 | -10.5K | 313.2K | -3% | -$51.4K | |
| 2024-03-12 | 2024-03-09 | AQST | Barber Daniel | Pres, CEO | F - Tax | $4.88 | -37.9K | 845.4K | -4% | -$185.1K | |
| D | 2024-03-11 | 2024-03-07 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | A - Grant | $0.00 | +82.5K | 1.07M | +8% | $0 |
| D | 2024-03-11 | 2023-03-10 | AQST | Jung Cassie | SVP, Ops | F - Tax | $0.00 | -1,365 | 145.9K | -0.9% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | Jung Cassie | SVP, Ops | A - Grant | $0.00 | +101.2K | 247.2K | +69% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | BRAENDER LORI J | SVP, GC | A - Grant | $0.00 | +135.0K | 323.8K | +72% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | Boyd Peter E. | See Remark | A - Grant | $0.00 | +86.2K | 246.0K | +54% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | Barber Daniel | Pres, CEO | A - Grant | $0.00 | +242.6K | 883.3K | +38% | $0 |
| D | 2024-03-11 | 2023-03-10 | AQST | Wargacki Stephen | SVP, Research, Development | F - Tax | $0.79 | -1,981 | 158.4K | -1% | -$1,565 |
| D | 2024-03-11 | 2024-03-07 | AQST | Wargacki Stephen | SVP, Research, Development | A - Grant | $0.00 | +112.5K | 270.9K | +71% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | TOTH A ERNEST JR | SVP, CFO | A - Grant | $0.00 | +120.0K | 260.0K | +86% | $0 |
| D | 2024-03-11 | 2024-03-07 | AQST | Kraus Carl N | Chief Medical Off | A - Grant | $0.00 | +112.5K | 262.5K | +75% | $0 |
| 2023-08-09 | 2023-08-09 | AQST | Kraus Carl N | Chief Medical Off | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations